Global Cancer Diagnostics Market – Trends and Forecast to 2024

1. Cancer Diagnostics Market – Global Industry Trends and Forecast to 2024 Global Cancer Diagnostics Market By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024 Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.

2. Key Drivers • Some of the major factors driving the market are growing aging population worldwide, government initiatives for funding, and awareness about cancer. Increasing prevalence of cancer, key players focusing are on strategic decisions and technological advancements are the major factors driving the growth of the cancer diagnostics market • Stringent regulations imposed by the international and local authorities and shortage of the skilled and trained professionals are the factors which may hinder the growth of this market. • Many companies are increasingly focusing on Next Generation Sequencing (NGS) and biopsy products in order to strengthen their product portfolios in the cancer diagnostics market. • Increasing demand for Magnetic Resonance Imaging (MRI) and Next Generation Sequencing (NGS) will drive the market in future.

3. Market Segmentation The market is segmented on the basis of technology and application, and geography. The global cancer diagnostics market, by technology, is categorized into two main segments—platform based and instrument-based. The global cancer diagnostics market, by application into lung cancer, breast cancer, colorectal cancer, melanoma and other forms of cancer. Breast cancer diagnosis is expected to hold the largest share of this market in 2015, due to very high prevalence in North America also due to very high cost of mammography instruments.

4. Regional Analysis • Based on geography the market is segmented into 5 geographical regions, • North America • Europe • Asia-Pacific • South America • Middle East and Africa. • The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others. Browse Full Report and Details TOC : http://databridgemarketresearch.com/reports/global-cancer-diagnostics-market/

5. Major Key Players • Major players in the Global Cancer Diagnostics Market are: • Abbott Laboratories, Inc. • ThermoFisher Scientific, Inc. • Illumina, Inc. • Becton, Dickinson and Company • GE Healthcare • QIAGEN N.V. • Agilent Technologies, Inc. • Roche Diagnostics • Siemens Healthcare Request Sample Report : http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market

6. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/

7. About Data Bridge Market Research Thank You • Contact Us : Data Bridge Market Research • Office Number 402, Amanora Chambers, • Magarpatta Road, Hadapsar • Pune – 411028 • Maharashtra, IndiaToll Free: +1-888-387-2818E-mail: sopan.gedam@databridgemarketresearch.com